Xuan Xue
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Xuan Xue has a total of 46 co-authors. Here are the top co-authors by number of shared publications:
- Aishah Nasir
Biodiscovery Institute University of Nottingham Nottingham NG7 2RD UK
1 shared publication Bincan Deng
1 shared publication- Bincan Deng
Sino‐Spain Joint Laboratory on Biomedical Materials (S2LBM) College of Materials Science and Engineering Nanjing Tech University Nanjing China
1 shared publication - Bo Chen
Institute of Materials Science and Devices, School of Materials Science and Engineering, Suzhou University of Science and Technology, Suzhou, China
1 shared publication Cameron Alexander
1 shared publicationChenxue Nie
School of Computer Science Faculty of Science University of Nottingham Nottingham NG8 1BB UK
1 shared publication
Latest Publications
- Open Access
- 11 August 2025
- Published by AccScience Publishing in Artificial Intelligence in Health
- Vol. 3 (1) , 025230052
Advances in three-dimensional bioprinting and artificial intelligence for enhanced tumor modeling: Current progress and future perspectives
Over the past decade, the global increase in cancer prevalence and cancer-related mortality has fueled extensive research to enhance the effectiveness of cancer treatments. Such efforts include the fabrication of lab-grown tissues and organs for transplantation, and the development of in vitro models for cancer drug testing and screening. Notably, three-dimensional (3D) tissue models offer advantages over two-dimensional cultures and have benefited from recent advancements in cutting-edge techniques like 3D printing, enabling the reconstruction of various tumor models in vitro. In this review, we focus on recent progress in in vitro 3D tumor models, with particular emphasis on the roles of 3D bioprinting and artificial intelligence. Furthermore, we provide future perspectives on employing bioprinting to develop tumor models that accurately mimic the complexity and heterogeneity of real tumor microenvironments.
- 11 August 2025
- Published by AccScience Publishing in Artificial Intelligence in Health
- Vol. 3 (1) , 025230052
Open AccessAdvances in three-dimensional bioprinting and artificial intelligence for enhanced tumor modeling: Current progress and future perspectives
Over the past decade, the global increase in cancer prevalence and cancer-related mortality has fueled extensive research to enhance the effectiveness of cancer treatments. Such efforts include the fabrication of lab-grown tissues and organs for transplantation, and the development of in vitro models for cancer drug testing and screening. Notably, three-dimensional (3D) tissue models offer advantages over two-dimensional cultures and have benefited from recent advancements in cutting-edge techniques like 3D printing, enabling the reconstruction of various tumor models in vitro. In this review, we focus on recent progress in in vitro 3D tumor models, with particular emphasis on the roles of 3D bioprinting and artificial intelligence. Furthermore, we provide future perspectives on employing bioprinting to develop tumor models that accurately mimic the complexity and heterogeneity of real tumor microenvironments.
- Open Access
- 15 July 2025
- Published by Elsevier in Materials Today Bio
- Vol. 33, 102061
Bioinspired 3D hydrogel scaffold to mimic tumor microenvironment for investigating into the anoikis resistance mechanisms in colorectal cancer
- 15 July 2025
- Published by Elsevier in Materials Today Bio
- Vol. 33, 102061
Open AccessBioinspired 3D hydrogel scaffold to mimic tumor microenvironment for investigating into the anoikis resistance mechanisms in colorectal cancer
- Open Access
- 10 September 2024
- Published by Elsevier in Cell Reports Physical Science
- Vol. 5 (9)
Discovery and computational modeling of adsorbent polymers that effectively immobilize SARS-CoV-2, with potential practical applications
- 10 September 2024
- Published by Elsevier in Cell Reports Physical Science
- Vol. 5 (9)
Open AccessDiscovery and computational modeling of adsorbent polymers that effectively immobilize SARS-CoV-2, with potential practical applications
- Open Access
- 22 August 2024
- Published by Wiley in Advanced Intelligent Systems
- Vol. 7 (5)
Computer Vision for Substrate Detection in High‐Throughput Biomaterial Screens Using Bright‐Field Microscopy
High‐throughput screening (HTS) can be used when ab initio information is unavailable for rational design of new materials, generating data on properties such as chemistry and topography that control cell behavior. Biomaterial screens are typically fabricated as microarrays or “chips,” seeded with the cell type of interest, then phenotyped using immunocytochemistry and high‐content imaging, generating vast quantities of image data. Typically, analysis is only performed on fluorescent cell images as it is relatively simple to automate through intensity thresholding of cellular features. Automated analysis of bright‐field images is rarely performed as it presents an automation challenge as segmentation thresholds that work in all images cannot be defined. This limits the biological insight as cell response cannot be correlated to specifics of the biomaterial feature (e.g., shape, size) as these features are not visible on fluorescence images. Computer Vision aims to digitize tasks humans do by sight, such as identify objects by their shape. Herein, two case studies demonstrate how open‐source approaches, (region‐based convolutional neural network and algorithmic [OpenCV]), can be integrated into cell‐biomaterial HTS analysis to automate bright‐field segmentation across thousands of images, allowing rapid, spatial definition of biomaterial features during cell analysis for the first time.
- 22 August 2024
- Published by Wiley in Advanced Intelligent Systems
- Vol. 7 (5)
Open AccessComputer Vision for Substrate Detection in High‐Throughput Biomaterial Screens Using Bright‐Field Microscopy
High‐throughput screening (HTS) can be used when ab initio information is unavailable for rational design of new materials, generating data on properties such as chemistry and topography that control cell behavior. Biomaterial screens are typically fabricated as microarrays or “chips,” seeded with the cell type of interest, then phenotyped using immunocytochemistry and high‐content imaging, generating vast quantities of image data. Typically, analysis is only performed on fluorescent cell images as it is relatively simple to automate through intensity thresholding of cellular features. Automated analysis of bright‐field images is rarely performed as it presents an automation challenge as segmentation thresholds that work in all images cannot be defined. This limits the biological insight as cell response cannot be correlated to specifics of the biomaterial feature (e.g., shape, size) as these features are not visible on fluorescence images. Computer Vision aims to digitize tasks humans do by sight, such as identify objects by their shape. Herein, two case studies demonstrate how open‐source approaches, (region‐based convolutional neural network and algorithmic [OpenCV]), can be integrated into cell‐biomaterial HTS analysis to automate bright‐field segmentation across thousands of images, allowing rapid, spatial definition of biomaterial features during cell analysis for the first time.
- Open Access
Synthesis of Thermo-Responsive Monofunctionalized Diblock Copolymer Worms
Poly(glycerol monomethacrylate)-block-poly(2-hydroxypropyl methacrylate) (PGMA-PHPMA) with worm-like morphology is a typical example of reversible addition–fragmentation chain transfer (RAFT) dispersion polymerized thermo-responsive copolymer via polymerization-induced self-assembly (PISA) in aqueous solution. Chain transfer agents (CTAs) are the key component in controlling RAFT, the structures of which determine the end functional groups of the polymer chain. It is therefore of interest to monofunctionalize the polymers via CTA moiety, for bioactive functionality conjugation and in the meantime maintain the precisely controlled morphology of the copolymers and the related property. In this work, a newly designed CTA 5-(2-(tert-butoxycarbonylamino) ethylamino)-2-cyano-5-oxopentan-2-yl benzodithioate (t-Boc CPDB) was synthesized and used for the RAFT polymerization of PGMA45-PHPMA120. Subsequently, PGMA45-PHPMA120 copolymers with primary amine, maleimide, and reduced L-glutathione (a tripeptide) monofunctionalized terminals were synthesized via deprotection and conjugation reactions. These monofunctionalized copolymers maintain worm-like morphology and thermo-responsive property in aqueous solution (10% w/v), as confirmed by the transmission electron microscopy (TEM) images, and the observation of the phase transition behavior in between 4 °C and room temperature (~20 °C), respectively. Summarily, a range of thermo-responsive monofunctionalized PGMA45-PHPMA120 diblock copolymer worms were successfully synthesized, which are expected to offer potential biomedical applications, such as in polymer therapeutics, drug delivery, and diagnostics.
Open AccessSynthesis of Thermo-Responsive Monofunctionalized Diblock Copolymer Worms
Poly(glycerol monomethacrylate)-block-poly(2-hydroxypropyl methacrylate) (PGMA-PHPMA) with worm-like morphology is a typical example of reversible addition–fragmentation chain transfer (RAFT) dispersion polymerized thermo-responsive copolymer via polymerization-induced self-assembly (PISA) in aqueous solution. Chain transfer agents (CTAs) are the key component in controlling RAFT, the structures of which determine the end functional groups of the polymer chain. It is therefore of interest to monofunctionalize the polymers via CTA moiety, for bioactive functionality conjugation and in the meantime maintain the precisely controlled morphology of the copolymers and the related property. In this work, a newly designed CTA 5-(2-(tert-butoxycarbonylamino) ethylamino)-2-cyano-5-oxopentan-2-yl benzodithioate (t-Boc CPDB) was synthesized and used for the RAFT polymerization of PGMA45-PHPMA120. Subsequently, PGMA45-PHPMA120 copolymers with primary amine, maleimide, and reduced L-glutathione (a tripeptide) monofunctionalized terminals were synthesized via deprotection and conjugation reactions. These monofunctionalized copolymers maintain worm-like morphology and thermo-responsive property in aqueous solution (10% w/v), as confirmed by the transmission electron microscopy (TEM) images, and the observation of the phase transition behavior in between 4 °C and room temperature (~20 °C), respectively. Summarily, a range of thermo-responsive monofunctionalized PGMA45-PHPMA120 diblock copolymer worms were successfully synthesized, which are expected to offer potential biomedical applications, such as in polymer therapeutics, drug delivery, and diagnostics.
- Open Access
- 18 May 2023
- Published by IMR Press in Reviews in Cardiovascular Medicine
- Vol. 24 (5) , 146
Analysis of Risk Factors for Major Adverse Cardiovascular Events in Patients with Coronary Stent Restenosis after Revascularization
Background: To investigate the risk factors for myocardial infarction, recurrent in-stent restenosis (ISR) and target vessel revascularization (TVR) in patients with coronary ISR within 4 years after revascularization. Methods: A total of 1884 patients who were hospitalized at Fuwai Hospital for ISR and successfully treated with coronary intervention between January 2017 and December 2018 were included to determine whether there were myocardial infarction, recurrent ISR, TVR and other major adverse cardiovascular events (MACEs) within 4 years after intervention. The patients were divided into the MACE group (215 patients) and the non-MACE group (1669 patients). The clinical data of patients in the two groups were compared, and the risk factors for postoperative MACEs in the ISR patients were obtained by multivariate logistic regression analysis. The receiver operating characteristic (ROC) curve was used to determine the optimal prediction threshold for postoperative MACEs in ISR patients. The difference in survival curves between the two groups was compared using Kaplan‒Meier survival analysis. Results: The albumin (43.42 ± 4.77 vs. 44.17 ± 4.46, p = 0.021), direct bilirubin (2.5 (2, 3.5) vs. 2.8 (2.07, 3.73), p = 0.036) and free triiodothyronine (FT3) (2.85 ± 0.43 vs. 2.92 ± 0.42, p = 0.019) levels in the MACE group were significantly lower than those in the non-MACE group, and there was a significant negative correlation between albumin and FT3 and MACEs. The results of univariate and multivariate logistic regression analyses revealed that FT3 was an independent predictor of postoperative MACEs in ISR patients (Odds Ratio (OR) = 0.626, 95% CI: 0.429–0.913, p = 0.015). The ROC curve analysis determined that an FT3 value of 2.785 pmol/L was the optimal prediction threshold. According to the threshold, ISR patients were divided into the FT3 <2.785 group and the FT3 ≥2.785 group. The Kaplan‒Meier analysis revealed that the postoperative recurrence rate of MACEs of the FT3 <2.785 group was substantially greater than that of the FT3 ≥2.785 group (Hazard Ratio (HR) = 0.76, 95% CI: 0.58–0.994, p = 0.044). Conclusions: FT3 can be used as an independent predictor of postoperative myocardial infarction, recurrent ISR and TVR in ISR patients. When FT3 is <2.785 pmol/L, the incidence of postoperative myocardial infarction, recurrent ISR and TVR in ISR patients increases significantly.
- 18 May 2023
- Published by IMR Press in Reviews in Cardiovascular Medicine
- Vol. 24 (5) , 146
Open AccessAnalysis of Risk Factors for Major Adverse Cardiovascular Events in Patients with Coronary Stent Restenosis after Revascularization
Background: To investigate the risk factors for myocardial infarction, recurrent in-stent restenosis (ISR) and target vessel revascularization (TVR) in patients with coronary ISR within 4 years after revascularization. Methods: A total of 1884 patients who were hospitalized at Fuwai Hospital for ISR and successfully treated with coronary intervention between January 2017 and December 2018 were included to determine whether there were myocardial infarction, recurrent ISR, TVR and other major adverse cardiovascular events (MACEs) within 4 years after intervention. The patients were divided into the MACE group (215 patients) and the non-MACE group (1669 patients). The clinical data of patients in the two groups were compared, and the risk factors for postoperative MACEs in the ISR patients were obtained by multivariate logistic regression analysis. The receiver operating characteristic (ROC) curve was used to determine the optimal prediction threshold for postoperative MACEs in ISR patients. The difference in survival curves between the two groups was compared using Kaplan‒Meier survival analysis. Results: The albumin (43.42 ± 4.77 vs. 44.17 ± 4.46, p = 0.021), direct bilirubin (2.5 (2, 3.5) vs. 2.8 (2.07, 3.73), p = 0.036) and free triiodothyronine (FT3) (2.85 ± 0.43 vs. 2.92 ± 0.42, p = 0.019) levels in the MACE group were significantly lower than those in the non-MACE group, and there was a significant negative correlation between albumin and FT3 and MACEs. The results of univariate and multivariate logistic regression analyses revealed that FT3 was an independent predictor of postoperative MACEs in ISR patients (Odds Ratio (OR) = 0.626, 95% CI: 0.429–0.913, p = 0.015). The ROC curve analysis determined that an FT3 value of 2.785 pmol/L was the optimal prediction threshold. According to the threshold, ISR patients were divided into the FT3 <2.785 group and the FT3 ≥2.785 group. The Kaplan‒Meier analysis revealed that the postoperative recurrence rate of MACEs of the FT3 <2.785 group was substantially greater than that of the FT3 ≥2.785 group (Hazard Ratio (HR) = 0.76, 95% CI: 0.58–0.994, p = 0.044). Conclusions: FT3 can be used as an independent predictor of postoperative myocardial infarction, recurrent ISR and TVR in ISR patients. When FT3 is <2.785 pmol/L, the incidence of postoperative myocardial infarction, recurrent ISR and TVR in ISR patients increases significantly.